Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 9478-9479 [2016-03928]
Download as PDF
<![CDATA[
9478
Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices
ICD–10–PCS Topics
Removal of Thrombus and Emboli
Insertion of Endobronchial Coils
Hematopoietic Cell Transplant Donor
Fluorescence Vascular Angiography
(FVA) (FVA)
Rapid Deployment Aortic Valve
Replacement Replacement
Branch Endograft Repair of Common
Iliac Aneurysm
Total Anomalous Pulmonary Venous
Return
Administration of Andexanet Alfa
Injection for I.V. Infusion
Administration of VISTOGARD (uridine
triacetate)
Mechanical Embolectomy with Stent
Retriever Retrieve
Intracranial Aneurysm Procedure Using
Flow Diverter Stent
Spinal Bracing and Distraction System
Interbody Spinal Fusion with NanoTextured Surface
Therapeutic Artificial Rupture of
Membranes
Application of Biologic Wound Matrix
(MircoDERM)
Oxidized Zirconium on Polyethylene
Bearing Surfaces
GEM Structure and Update Requests
Addenda and Key Updates
ICD–10–CM Diagnosis Topics
mstockstill on DSK4VPTVN1PROD with NOTICES
Antenatal Screening
Clostridium difficile
Congential Sacral Dimple
Exercise Counseling
Hepatic Encephalopathy
Lacunar Infarction
Pediatric Cryptorchidism
Post-operative Seroma
Soft Tissue Sarcoma
Spinal Stenosis
Temporomandibular Joint Disorders
Zika Virus Infection
ICD–10–CM Addendum
Agenda items are subject to change as
priorities dictate.
Note: CMS and NCHS no longer provide
paper copies of handouts for the meeting.
Electronic copies of all meeting materials
will be posted on the CMS and NCHS Web
sites prior to the meeting at https://
www.cms.hhs.gov/ICD9Provider
DiagnosticCodes/03_
meetings.asp#TopOfPage and https://
www.cdc.gov/nchs/icd/icd9cm_
maintenance.htm
Contact Persons for Additional
Information: Donna Pickett, Medical Systems
Administrator, Classifications and Public
Health Data Standards Staff, NCHS, 3311
Toledo Road, Hyattsville, Maryland 20782,
email dfp4@cdc.gov, telephone 301–458–
4434 (diagnosis); Mady Hue, Health
Insurance Specialist, Division of Acute Care,
CMS, 7500 Security Boulevard, Baltimore,
Maryland 21244, email marilu.hue@
cms.hhs.gov, telephone 410–786–4510
(procedures).
VerDate Sep<11>2014
18:07 Feb 24, 2016
Jkt 238001
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–03930 Filed 2–24–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Times and Dates: 9:00 a.m.–5:00 p.m.,
Eastern Time, March 23, 2015; 8:15
a.m.–12:30 p.m., Eastern Time, March
24, 2015.
Public Comment Time and Date: 5:00
p.m.–6:00 p.m.*, Eastern Time, March
23, 2015.
* Please note that the public comment
period may end before the time
indicated, following the last call for
comments. Members of the public who
wish to provide public comments
should plan to attend the public
comment session at the start time listed.
Place: Hilton Tampa Airport
Westshore, 2225 N. Lois Avenue,
Tampa, Florida 33607; Phone: (800)
445–8667; Fax: (813) 872–0603. Audio
Conference Call via FTS Conferencing.
The USA toll-free, dial-in number is
1–866–659–0537 with a pass code of
9933701. Live Meeting CONNECTION:
https://www.livemeeting.com/cc/cdc/
join?id=GHFDT9&role=attend&pw=
ABRWH; Meeting ID: GHFDT9; Entry
Code: ABRWH.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2017.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters for Discussion: The agenda for
the Advisory Board meeting includes:
NIOSH Program Update; Department of
Labor Program Update; Department of
Energy Program Update; Report by the
Dose Reconstruction Review Methods
Work Group; Dose Reconstruction
Report to the Secretary; SEC Petitions
Update; Site Profile review for: Pinellas
Plant (Clearwater, Florida); SEC
petitions for: Lawrence Livermore
National Laboratory (1974–1995;
Livermore, California), Idaho National
Laboratory (1949–1970; Scoville, Idaho),
and Argonne National Laboratory West
(1951–1979; Scoville, Idaho); and Board
Work Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
E:\FR\FM\25FEN1.SGM
25FEN1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices
submitted to the contact person below
well in advance of the meeting. Any
written comments received will be
provided at the meeting in accordance
with the redaction policy provided
below.
Policy on Redation of Board Meeting
Transcripts (Public Comment):
(1) If a person making a comment
gives his or her personal information, no
attempt will be made to redact the
name; however, NIOSH will redact
other personally indentifiable
information, such as contact
information, social security numbers,
case numbers, etc., of the commenter.
(2) If an individual in making a
statement reveals personal information
(e.g., medical or employment
information) about themselves that
information will not usually be
redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator
will, however, review such revelations
in accordance with the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information.
(3) If a commenter reveals personal
information concerning a living third
party, that information will be reviewed
by the NIOSH FOIA coordinator, and
upon determination, if deemed
appropriated, such information will be
redacted, unless the disclosure is made
by the third party’s authorized
representative under the Energy
Employees Occupational Illness
Compensation Program Act (EEOICPA)
program.
(4) In general, information concerning
a deceased third party may be disclosed;
however, such information will be
redacted if (a) the disclosure is made by
an individual other than the survivor
claimant, a parent, spouse, or child, or
the authorized representative of the
deceased third party; (b) if it is unclear
whether the third party is living or
deceased; or (c) the information is
unrelated or irrelevant to the purpose of
the disclosure.
The Board will take reasonable steps
to ensure that individuals making
public comment are aware of the fact
that their comments (including their
name, if provided) will appear in a
transcript of the meeting posted on a
public Web site. Such reasonable steps
include: (a) A statement read at the start
of each public comment period stating
that transcripts will be posted and
names of speakers will not be redacted;
(b) A printed copy of the statement
mentioned in (a) above will be
displayed on the table where
individuals sign up to make public
comments; (c) A statement such as
VerDate Sep<11>2014
19:51 Feb 24, 2016
Jkt 238001
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road
NE., MS E–20, Atlanta, Georgia 30333,
telephone: (513) 533–6800, toll free: 1–
800–CDC–INFO, email: dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–03928 Filed 2–24–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Board of
Scientific Counselors, Office of Public
Health Preparedness and Response
(BSC, OPHPR)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the BSC, OPHPR. The BSC, OPHPR
consists of 11 experts in the fields
associated with public health
preparedness and response. This board
provides advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), the Director,
CDC, and the Director, OPHPR,
concerning strategies and goals for the
programs within the divisions; conducts
peer-review of scientific programs; and
monitors the overall strategic direction
and focus of the divisions. The BSC,
OPHPR may perform second-level peer
review of applications for grants-in-aid
for research and research training
activities, cooperative agreements, and
research contract proposals relating to
the broad areas within the office (https://
www.cdc.gov/phpr/science/
counselors.htm).
Nominations are being sought for
individuals who have the expertise and
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
9479
qualifications necessary to contribute to
accomplishment of the board’s
objectives. Nominees will be selected
based on expertise in the fields relevant
to the issues addressed by the divisions
within the coordinating office,
including: business, crisis leadership,
emergency response and management,
engineering, epidemiology, health
policy and management, informatics,
laboratory science, medicine, mental
and behavioral health, public health
law, public health practice, risk
communication, and social science.
Federal employees will not be
considered for membership. Members
may be invited to serve for terms of up
to four years.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership be balanced in
terms of professional training and
background, points of view represented,
and the board’s function. Consideration
is given to a broad representation of
geographic areas within the U.S., with
equitable representation of gender, all
ethnic and racial groups, and persons
with disabilities. Nominees must be
U.S. citizens.
The next cycle of selection of
candidates will begin in the spring of
2016, for selection of potential
nominees to replace members whose
terms will end on September 30, 2016.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of OPHPR
objectives (https://www.cdc.gov/phpr/
about.htm).
Candidates should submit the
following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address)
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
The deadline for receipt of all
application materials (for consideration
for term beginning October 1, 2016) is
April 15, 2016. All files must be
submitted electronically as email
attachments to: CDR Christye Brown,
c/o BSC OPHPR Coordinator, email:
cbrown12@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 81, Number 37 (Thursday, February 25, 2016)]
[Notices]
[Pages 9478-9479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03928]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Times and Dates: 9:00 a.m.-5:00 p.m., Eastern Time, March 23, 2015;
8:15 a.m.-12:30 p.m., Eastern Time, March 24, 2015.
Public Comment Time and Date: 5:00 p.m.-6:00 p.m.*, Eastern Time,
March 23, 2015.
* Please note that the public comment period may end before the
time indicated, following the last call for comments. Members of the
public who wish to provide public comments should plan to attend the
public comment session at the start time listed.
Place: Hilton Tampa Airport Westshore, 2225 N. Lois Avenue, Tampa,
Florida 33607; Phone: (800) 445-8667; Fax: (813) 872-0603. Audio
Conference Call via FTS Conferencing. The USA toll-free, dial-in number
is 1-866-659-0537 with a pass code of 9933701. Live Meeting CONNECTION:
https://www.livemeeting.com/cc/cdc/join?id=GHFDT9&role=attend&pw=ABRWH;
Meeting ID: GHFDT9; Entry Code: ABRWH.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule, advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2017.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters for Discussion: The agenda for the Advisory Board meeting
includes: NIOSH Program Update; Department of Labor Program Update;
Department of Energy Program Update; Report by the Dose Reconstruction
Review Methods Work Group; Dose Reconstruction Report to the Secretary;
SEC Petitions Update; Site Profile review for: Pinellas Plant
(Clearwater, Florida); SEC petitions for: Lawrence Livermore National
Laboratory (1974-1995; Livermore, California), Idaho National
Laboratory (1949-1970; Scoville, Idaho), and Argonne National
Laboratory West (1951-1979; Scoville, Idaho); and Board Work Sessions.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
[[Page 9479]]
submitted to the contact person below well in advance of the meeting.
Any written comments received will be provided at the meeting in
accordance with the redaction policy provided below.
Policy on Redation of Board Meeting Transcripts (Public Comment):
(1) If a person making a comment gives his or her personal
information, no attempt will be made to redact the name; however, NIOSH
will redact other personally indentifiable information, such as contact
information, social security numbers, case numbers, etc., of the
commenter.
(2) If an individual in making a statement reveals personal
information (e.g., medical or employment information) about themselves
that information will not usually be redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator will, however, review such
revelations in accordance with the Federal Advisory Committee Act and
if deemed appropriate, will redact such information.
(3) If a commenter reveals personal information concerning a living
third party, that information will be reviewed by the NIOSH FOIA
coordinator, and upon determination, if deemed appropriated, such
information will be redacted, unless the disclosure is made by the
third party's authorized representative under the Energy Employees
Occupational Illness Compensation Program Act (EEOICPA) program.
(4) In general, information concerning a deceased third party may
be disclosed; however, such information will be redacted if (a) the
disclosure is made by an individual other than the survivor claimant, a
parent, spouse, or child, or the authorized representative of the
deceased third party; (b) if it is unclear whether the third party is
living or deceased; or (c) the information is unrelated or irrelevant
to the purpose of the disclosure.
The Board will take reasonable steps to ensure that individuals
making public comment are aware of the fact that their comments
(including their name, if provided) will appear in a transcript of the
meeting posted on a public Web site. Such reasonable steps include: (a)
A statement read at the start of each public comment period stating
that transcripts will be posted and names of speakers will not be
redacted; (b) A printed copy of the statement mentioned in (a) above
will be displayed on the table where individuals sign up to make public
comments; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in the
Federal Register Notice that announces Board and Subcommittee meetings.
Contact Person for More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta,
Georgia 30333, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO,
email: dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-03928 Filed 2-24-16; 8:45 am]
BILLING CODE 4163-18-P
